| The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice E Elia, V Sander, CG Luchetti, ME Solano, G Di Girolamo, C Gonzalez, ... MHR: Basic science of reproductive medicine 12 (8), 475-481, 2006 | 126 | 2006 |
| Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function CG Luchetti, ME Solano, V Sander, MLB Arcos, C Gonzalez, ... Journal of reproductive immunology 64 (1-2), 59-74, 2004 | 123 | 2004 |
| Mechanisms of drug induced QT interval prolongation ML Ponte, GA Keller, GD Girolamo Current drug safety 5 (1), 44-53, 2010 | 112 | 2010 |
| Role of the N, N′-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone V Sander, CG Luchetti, ME Solano, E Elia, G Di Girolamo, C Gonzalez, ... Reproduction 131 (3), 591-602, 2006 | 104 | 2006 |
| Dual effect of nitric oxide on uterine prostaglandin synthesis in a murine model of preterm labour M Cella, MG Farina, AP Dominguez Rubio, G Di Girolamo, ML Ribeiro, ... British Journal of Pharmacology 161 (4), 844-855, 2010 | 73 | 2010 |
| Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach B Oliveri, SR Mastaglia, GM Brito, M Seijo, GA Keller, J Somoza, RA Diez, ... European journal of clinical nutrition 69 (6), 697-702, 2015 | 66 | 2015 |
| Other drugs acting on nervous system associated with QT-interval prolongation GA Keller, ML Ponte, G Di Girolamo Current drug safety 5 (1), 105-111, 2010 | 65 | 2010 |
| Drug-induced QT interval prolongation in the intensive care unit CV Etchegoyen, GA Keller, S Mrad, S Cheng, G Di Girolamo Current clinical pharmacology 12 (4), 210-222, 2017 | 58 | 2017 |
| Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor MA Giorgi, H Cohen Arazi, CD Gonzalez, G Di Girolamo Expert opinion on pharmacotherapy 12 (8), 1285-1295, 2011 | 58 | 2011 |
| QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications MA Giorgi, R Bolanos, CD Gonzalez, G Di Girolamo Current drug safety 5 (1), 54-57, 2010 | 50 | 2010 |
| Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study G Di Girolamo, P Czerniuk, R Bertuola, GA Keller Clinical therapeutics 32 (1), 161-170, 2010 | 49 | 2010 |
| Antimicrobial agents-associated with QT interval prolongation F Bril, CD Gonzalez, G Di Girolamo Current Drug Safety 5 (1), 85-92, 2010 | 44 | 2010 |
| Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice ME Solano, E Elia, CG Luchetti, V Sander, G Di Girolamo, C Gonzalez, ... Reproduction, Fertility and Development 18 (5), 533-544, 2006 | 44 | 2006 |
| The influence of dehydroepiandrosterone on early pregnancy in mice V Sander, ME Solano, E Elia, CG Luchetti, G Di Girolamo, C Gonzalez, ... Neuroimmunomodulation 12 (5), 285-292, 2005 | 42 | 2005 |
| Pharmacotherapy and motor recovery after stroke L Viale, NP Catoira, G Di Girolamo, CD González Expert Review of Neurotherapeutics 18 (1), 65-82, 2018 | 36 | 2018 |
| Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea? G Di Girolamo, AJ Sánchez, AR De Los Santos, CD González Expert Opinion on Pharmacotherapy 5 (3), 561-570, 2004 | 36 | 2004 |
| Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial M Cannellotto, M Duarte, G Keller, R Larrea, E Cunto, V Chediack, ... Emergency Medicine Journal 39 (2), 88-93, 2022 | 35 | 2022 |
| Drug-induced QTc interval prolongation: a multicenter study to detect drugs and clinical factors involved in every day practice G A Keller, P A Alvarez, M L Ponte, W H Belloso, C Bagnes, ... Current Drug Safety 11 (1), 86-98, 2016 | 35 | 2016 |
| Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina PA Alvarez, F Bril, V Castro, I Meiville, CD Gonzalez, IG Centurion, ... International journal of risk & safety in medicine 25 (3), 185-192, 2013 | 35 | 2013 |
| Investigational treatments for Type 2 diabetes mellitus: exenatide and liraglutide C González, V Beruto, G Keller, S Santoro, G Di Girolamo Expert opinion on investigational drugs 15 (8), 887-895, 2006 | 34 | 2006 |
